综合基因组分析在临床实践中的预后获益仍不确定。
Prognostic benefit of comprehensive genomic profiling in clinical practice remains uncertain.
机构信息
Department of Musculoskeletal Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
出版信息
Cancer Sci. 2023 Jul;114(7):3053-3055. doi: 10.1111/cas.15826. Epub 2023 Apr 30.
Abstract
The overall survival of patients who received genomically matched therapy was not significantly longer than that of patients receiving treatment only other than genomically matched therapy in the breast invasive ductal carcinoma (A), colorectal adenocarcinoma (B), and pancreatic adenocarcinoma (C) cohorts.
摘要
在乳腺癌浸润性导管癌（A）、结直肠腺癌（B）和胰腺腺癌（C）队列中，接受基因匹配治疗的患者的总生存率与仅接受其他基因治疗的患者相比并没有显著延长。
Zotero 插件